glp 1 pediatric obesity trials aim to expand GLP-1 weight loss drugs to younger children Researchers at UC Irvine issue

Many patients hit a comfortable rhythm of 2 small meals plus a protein-rich snack daily

Further optimization and development of GPX4 activators are expected to provide novel solutions for treating inflammation and other lipid-peroxidation-mediated diseases

Del Prato S, Kahn SE, Pavo I et al (2021) Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

The roles of histone deacetylases in kidney development and disease

doi: 10.1177/1535370221995785 [DOI] [PMC free article] [PubMed] [Google Scholar] 183.Muscar C, Gugliandolo A, Mazzon E, Cal G